Overview: Neopterin TestIntroduction: The Neopterin Test measures neopterin to diagnose immune activation or infections, causing fever or fatigue. Aligned with 2023 IDSA guidelines, it uses biochemistry methods for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected immune activation or chronic infections.
Other Names: Neopterin Assay, Immune Activation Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Neopterin testing began in the 1980s with immune activation research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures neopterin to diagnose immune activation or infections, guides treatment, and evaluates patients with fever or fatigue.
Test Parameters: 1. Neopterin Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum, plasma, or urine. Report history of fever, fatigue, or chronic infections.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, fatigue, weight loss, or history of chronic infections (e.g., HIV). Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, immune activation implications, and risks of sample collection.
Procedural Considerations: Uses biochemistry methods (e.g., high-performance liquid chromatography) to measure neopterin in specimens. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for immune activation diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Recent infections may elevate levels.
Clinical Significance: Elevated neopterin suggests immune activation or infection, guiding further diagnostic workup. Normal levels may require additional testing.
Specialist Consultation: Consult an infectious disease specialist or immunologist for result interpretation and treatment planning.
Additional Supporting Tests: CRP, ESR, or viral load testing to confirm immune activation or infection diagnosis.
Test Limitations: Not specific to one infection; clinical correlation is needed. Sample quality affects accuracy.
References: IDSA Immune Activation Guidelines, 2023; Journal of Clinical Immunology, Fuchs D, 2022.
